Baxter International (BAX) Common Equity (2009 - 2026)

Baxter International (BAX) has reported Common Equity for 18 consecutive years, with $6.2 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Common Equity fell 14.9% year-over-year to $6.2 billion in Q2 2026; TTM through Jun 2026 was $6.2 billion, a 14.9% decrease from a year earlier, with the FY2025 full-year figure at $6.1 billion, down 12.74% from the prior year.
• Common Equity was $6.2 billion for Q2 2026 at Baxter International, up from $6.0 billion in the prior quarter.
• Over five years, Common Equity peaked at $9.1 billion in Q1 2022 and troughed at $5.6 billion in Q3 2022.
• A 5-year average of $7.1 billion and a median of $7.1 billion in 2025 frame the typical range for Common Equity.
• The widest YoY moves for Common Equity: up 46.37% in 2023, down 36.75% in 2023.
• Over 5 years, Common Equity stood at $5.9 billion in 2022, then soared by 43.65% to $8.5 billion in 2023, then decreased by 17.05% to $7.0 billion in 2024, then decreased by 12.74% to $6.1 billion in 2025, then gained by 1.26% to $6.2 billion in 2026.
• The last three Common Equity figures came in at $6.2 billion (Q2 2026), $6.0 billion (Q1 2026), and $6.1 billion (Q4 2025), per Business Quant data.